VaramirStart free · no cardSign in
TSHA as of Oct 31 · 14:28 ET
TSHANasdaqBiological Products, (No Diagnostic Substances)

Taysha Gene Therapies, Inc. · Brief

Next report

3 days

Nov 3 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 8≥ implied
avg implied
±21.2%
avg realized
±4.0%
Nov 13 '24±24.0%▲+2.71%×0.11
Feb 26 '25±38.4%▼−4.71%×0.12
May 15 '25±27.2%▲+8.02%×0.29
Aug 12 '25±17.9%▲+5.43%×0.30
Q3 FY25±22.5%▼−4.26%×0.19
Q1 FY26±12.0%▲+2.47%×0.21
May 6 '26±14.4%▲+0.58%×0.04
Q2 FY26±13.4%▼−4.12%×0.31
quarterimplied−40%0+40%realized×
Q2 FY26±13.4%▼−4.12%×0.31
May '26±14.4%▲+0.58%×0.04
Q1 FY26±12.0%▲+2.47%×0.21
Q3 FY25±22.5%▼−4.26%×0.19
Aug '25±17.9%▲+5.43%×0.30
May '25±27.2%▲+8.02%×0.29
2 older reports
Feb '25±38.4%▼−4.71%×0.12
Nov '24±24.0%▲+2.71%×0.11
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 3 report · est.

Bull2 of 3

11disclosed supplier and customer ties in SEC filings showing commercial connectivitySEC filings
208managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

5 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
23managers whose positions together make up four fifths of the reported value13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

TSHA report session

Suppliers 1

ABEOAbeona×0.21
× = co-movement · max 501dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 20impliedImplied move: ±18.9% into Nov 3 earnings (Oct 20 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.